69 related articles for article (PubMed ID: 1527187)
1. [Adenocarcinoma on endobrachyesophagus. Results and prognostic factors apropos of 19 cases surgically-treated].
Michel C; Launoy G; Maurel J; Auvray S; Segol P; Gignoux M
J Chir (Paris); 1992 Apr; 129(4):187-90. PubMed ID: 1527187
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
3. [Adenocarcinoma in Barrett's esophagus: long-term results of curative resection].
Peracchia A; Bonavina L; Pavanello M; Montorsi M; Ruol A; Segalin A
Chir Ital; 1994; 46(3):1-4. PubMed ID: 7528110
[TBL] [Abstract][Full Text] [Related]
4. Changing patterns and surgical results in adenocarcinoma of the oesophagus.
Thomas P; Doddoli C; Lienne P; Morati N; Thirion X; Garbe L; Giudicelli R; Fuentes P
Br J Surg; 1997 Jan; 84(1):119-25. PubMed ID: 9043475
[TBL] [Abstract][Full Text] [Related]
5. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
6. [Adenocarcinoma of the gastro-esophagus junction associated to endobrachyesophagus. Two case reports. Review of the literature].
Kreiker J; Daou R
J Med Liban; 2004; 52(2):103-10. PubMed ID: 15884690
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
9. A clinico-pathological study of the origin of adeno-carcinoma of the mid-thoracic oesophagus and results of surgical resection.
Moghissi K; Papiri N
Chirurgie; 1992; 118(5):298-303; discussion 304. PubMed ID: 1341284
[TBL] [Abstract][Full Text] [Related]
10. [Surgical treatment of primary adenocarcinoma of the esophagus].
Chen YH
Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):371-3. PubMed ID: 2276332
[TBL] [Abstract][Full Text] [Related]
11. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
[TBL] [Abstract][Full Text] [Related]
12. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
[TBL] [Abstract][Full Text] [Related]
13. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma arising in Barrett's esophagus.
Li H; Walsh TN; Hennessy TP
Surg Gynecol Obstet; 1992 Aug; 175(2):167-72. PubMed ID: 1636141
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
16. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
17. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
19. Exclusive radical surgery for esophageal adenocarcinoma.
Collard JM
Cancer; 2001 Mar; 91(6):1098-104. PubMed ID: 11267954
[TBL] [Abstract][Full Text] [Related]
20. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
